Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amexdrug Corporation is a diversified healthcare holding company that operates through several subsidiaries in the pharmaceutical and skincare sectors. The company's primary business involves the distribution of generic pharmaceuticals and the development of over-the-counter dermatological products through its subsidiary, Dermagen. Additionally, through Allied Health Management, the company provides pharmacy services to long-term care facilities and institutional clients. Amexdrug is publicly traded and focuses on the commercialization of health and beauty products alongside its core pharmaceutical distribution operations. The company has historically sought to expand its footprint in the healthcare market by acquiring and managing specialized pharmacy and distribution assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amexdrug.